跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,126 条关于
“CDK pathway”
全部
10,126
临床试验
4,104
药物
928
机构
33
资讯
5,061
8个月前
Abemaciclib Shows Promise in Aggressive Meningiomas with Specific Genetic Mutations
去年
Abemaciclib Shows Promise in Meningioma, Disappoints in Glioblastoma Combination
去年
Roche Acquires Regor Therapeutics' CDK Inhibitors for Breast Cancer Treatment
去年
China Approves Xuanyuening (Bireociclib): First Dual-Indication CDK Inhibitor for Advanced Breast Cancer
11个月前
Breast Cancer R&D Pipeline Expands to Over 300 Drugs with Novel PROTACs, ADCs, and CDK Inhibitors
4个月前
Avenzo Therapeutics Initiates CDK4/CDK2 Dual Inhibitor Combination Trial for HR+/HER2- Breast Cancer
9年前
Ribociclib Shows Promise in Advanced Breast Cancer Treatment
去年
House Introduces Bill for Conditional FDA Approval Pathway for Rare Disease Drugs
去年
FDA Clears Avenzo Therapeutics' IND for AVZO-023, a Novel CDK4 Selective Inhibitor for Advanced Breast Cancer
去年
Error parsing response
第 1 页,共 507 页
上一页
下一页